PRIMARY SCREENING definition

PRIMARY SCREENING means conducting an assay, screen or other test on a Collaboration Compound under the Research to determine physical chemical profiles and in vitro pharmacological and toxicological profiles.
PRIMARY SCREENING means use of an Aurora Assay to determine potential therapeutic or pharmaceutical activity or efficacy of compounds in the Aurora Compound Library.
PRIMARY SCREENING shall refer to high throughput synthesis or screening * with throughput significantly higher than Symyx' secondary screening devices generally made available to Third Parties as Discovery Tools (e.g. PPR(R) and multi-channel fixed bed reactors). "Non-Primary Screening" shall mean all synthesis or screening activities that are not Primary Screening activities.

Examples of PRIMARY SCREENING in a sentence

  • PRIMARY SCREENING PROCEDURE: There will be signs at the gates directing primary screening and ID checks.

  • Initially, LIGAND shall be responsible for conducting PRIMARY SCREENING and SECONDARY SCREENING of candidate RESEARCH COMPOUNDS as set forth in the RESEARCH PROGRAM and as designated by the LRC and shall regularly inform the LRC of the progress and results thereof.

  • URINE FLOW CYTOMETRY AS A PRIMARY SCREENING METHOD TO EXCLUDE URINARY TRACT INFECTIONS.

  • In the event a Participant has not made an election under Section 5.2 that is effective upon Separation from Service, then the Participant shall receive a lump sum distribution under Section 5.2.

  • Such additional PRIMARY SCREENING MODULES are also referred to in this AMENDMENT as the "ADDITIONAL MODULES", but shall, for all purposes of the AGREEMENT, be treated as PRIMARY SCREENING MODULES.

  • CONTENTS ABSTRACT TITLE: DIAGNOSTIC EFFICACY OF THIN PREP PREPARATION (LIQUID BASED CYTOLOGY) IN COMPARISON TO CONVENTIONAL PAP SMEARS AS A PRIMARY SCREENING TOOL FOR CERVICAL LESIONS.

  • Each Assay approved by the Research Committee for use in Phase 2 of the Research Project (each, an "APPROVED PRIMARY SCREENING ASSAY") shall be utilized by the Company in Phase 2 of the Research Project.

  • The LEAD CANDIDATE PRIMARY SCREENING PROGRAM shall be carried out by CUBIST, at CUBIST's sole cost and expense.

  • It is agreed by CUBIST and MERCK that no additional payments shall be due under Sections 3.1, 3.2 or 3.3 of the ORIGINAL AMENDED AGREEMENT regarding the LEAD CANDIDATE PRIMARY SCREENING PROGRAM or the LEAD to CANDIDATE SECONDARY SCREENING PROGRAM, notwithstanding that additional assays are to be conducted in connection therewith as provided in Paragraph 2 of the AMENDMENT NO.

  • The use of unified models in SST represents a particularly attractive paradigm since it provides a natural mechanism for speaker-adaptive TTS by employing the same speaker de- pendent transforms learned from ASR, while offering further efficiency with respect to computation and memory (see for eg.


More Definitions of PRIMARY SCREENING

PRIMARY SCREENING means conducting any assay, screen or other test on a compound under the Research Program to determine initially whether such compound functions as an agonist or antagonist of activity mediated through a Designated Receptor.
PRIMARY SCREENING means conducting any assay, screen or other test on a compound under the Research Program to determine initially whether such compound mediates the activity of the Designated Target, including without limitation such assays, screens and other tests set forth in the Technical Operating Plan and which Ligand currently has in its possession.
PRIMARY SCREENING means conducting any assay, screen or other test on a compound under the Research Program to determine initially whether such compound mediates the activity of the Designated Target, including without limitation such assays, screens and other tests set forth in the Technical
PRIMARY SCREENING means assessment of BI and VP COMPOUNDS in the high-throughput assay for inhibition of hepatitis C virus helicase activity.
PRIMARY SCREENING means conducting any cell based or other assay, screen or other test on a compound under the RESEARCH PROGRAM to determine initially, to the extent the assay is able to do so, whether such compound functions as a MODULATOR of activity mediated through the DESIGNATED PATHWAY.
PRIMARY SCREENING means conducting any cell based or other assay, screen or other test on a compound under the RESEARCH PROGRAM to determine initially, to the extent the assay is able to do so, whether such

Related to PRIMARY SCREENING

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Alcohol Screening Device (ASD) means a breath or saliva device, other than an Evidential Breath Testing Device (EBT), that is approved by the National Highway Traffic Safety Administration and placed on its Conforming Products List for such devices.

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • HCD means the California Department of Housing and Community Development.

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Collaborating physician means the physician who,

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Diagnostic mammography means a method of screening that

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Screening Test Technician (STT) means anyone who instructs and assists individuals in the alcohol testing process and operates an ASD.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Studies means activities needed to prepare project implementation, such as preparatory, mapping, feasibility, evaluation, testing and validation studies, including in the form of software, and any other technical support measure, including prior action to define and develop a project and decide on its financing, such as reconnaissance of the sites concerned and preparation of the financial package;

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.